Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Levasseur

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Nature Communications|April 7, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|June 25, 2023
Human Rotator Cuff Tears Reveal an Age-Dependent Increase in Markers of Cellular Senescence and Selective Removal of Senescent Cells With Dasatinib + Quercetin Increases Genetic Expression of COL1A1 In VitroBenjamin C Hawthorne, Ian J Wellington, Joshua T Sabitsky, et al.
Brain, Behavior, and Immunity|November 6, 2024
Tumor-derived cyclooxygenase-2 fuels hypothalamic inflammationXiaolin Li, Xinxia Zhu, Parham Diba, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
ACS Nano|August 26, 2024
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 AxisTetiana Korzun, Abraham S Moses, Antony Jozic, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Nature Communications|April 7, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 18, 2026
Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancerPaige C Arneson-Wissink, Alexandra Q Bartlett, Heike Mendez, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|June 25, 2023
Human Rotator Cuff Tears Reveal an Age-Dependent Increase in Markers of Cellular Senescence and Selective Removal of Senescent Cells With Dasatinib + Quercetin Increases Genetic Expression of COL1A1 In VitroBenjamin C Hawthorne, Ian J Wellington, Joshua T Sabitsky, et al.
Brain, Behavior, and Immunity|November 6, 2024
Tumor-derived cyclooxygenase-2 fuels hypothalamic inflammationXiaolin Li, Xinxia Zhu, Parham Diba, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
ACS Nano|August 26, 2024
Lipid Nanoparticles Elicit Reactogenicity and Sickness Behavior in Mice Via Toll-Like Receptor 4 and Myeloid Differentiation Protein 88 AxisTetiana Korzun, Abraham S Moses, Antony Jozic, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 13, 2022
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated CachexiaTetiana Korzun, Abraham S Moses, Jeonghwan Kim, et al.
ACS Nano|November 21, 2024
Targeting Metastasis in Head and Neck Squamous Cell Carcinoma Using Follistatin mRNA Lipid NanoparticlesVladislav Grigoriev, Tetiana Korzun, Abraham S Moses, et al.
Pageof 8